Viewing Study NCT02390050


Ignite Creation Date: 2025-12-24 @ 5:02 PM
Ignite Modification Date: 2026-02-20 @ 1:33 PM
Study NCT ID: NCT02390050
Status: COMPLETED
Last Update Posted: 2021-06-29
First Post: 2015-03-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
Sponsor: Theracos
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: THR-1442-C-449
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators